874974-96-6

Basic information

• Product Name: [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester
• Synonyms: [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester
• CAS NO: 874974-96-6
• Molecular Weight: 432.63
• Mol File: 874974-96-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester(874974-96-6)
• EPA Substance Registry System: [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester(874974-96-6)

Safety Data

• Hazardous Substances Data: 874974-96-6(Hazardous Substances Data)

Upstream product

• 1093987-88-2 1,1-dimethylethyl ethyl {3-[(3-bromo-5-chlorophenyl)oxy]-2-fluoro-4-nitrophenyl}propanedioate 
• 1093267-98-1 2-[(3-bromo-5-chlorophenyl)oxy]-3,4-difluoro-1-nitrobenzene 
• 56962-04-0 3-bromo-5-chlorophenol 
• 174913-12-3 1-bromo-3-chloro-5-methoxybenzene 
• 33863-76-2 1-bromo-3-chloro-5-fluorobenzene 
• 317356-84-6 ethyl (2,3-difluoro-4-nitrophenyl)acetate 

Downstream Products

• 1093988-12-5 3-chloro-5-({6-chloro-3-[(5-{3-[(difluoromethyl)oxy]phenyl}-1,3,4-oxadiazol-2-yl)methyl]-2-fluorophenyl}oxy)benzonitrile 
• 1093988-13-6 2-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-5-{3-[(difluoromethyl)oxy]phenyl}-1,3,4-oxadiazole 
• 1093988-10-3 3-chloro-5-{[6-chloro-3-({5-[3-(dimethylamino)phenyl]-1,3,4-oxadiazol-2-yl}methyl)-2-fluorophenyl]oxy}benzonitrile 
• 1093988-11-4 3-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]-N,N-dimethylaniline 
• 1093988-08-9 3-chloro-5-[(6-chloro-2-fluoro-3-{[5-(2-fluoro-3-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]methyl}phenyl)oxy]benzonitrile 
• 1093988-06-7 3-chloro-5-{[6-chloro-2-fluoro-3-({5-[2-fluoro-3-(methyloxy)phenyl]-1,3,4-oxadiazol-2-yl}methyl)phenyl]oxy}benzonitrile 
• 1093988-07-8 2-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-5-[2-fluoro-3-(methyloxy)phenyl]-1,3,4-oxadiazole 
• 1093988-04-5 3-chloro-5-[(6-chloro-3-{[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]methyl}-2-fluorophenyl)oxy]benzonitrile 
• 1093988-05-6 4-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]benzonitrile 
• 1093988-01-2 4-[5-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]-N,N-diethylbenzenesulfonamide 
• 1093988-03-4 4-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]-N,N-diethylbenzenesulfonamide 
• 1093988-02-3 4-{[2-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}acetyl)hydrazino]carbonyl}-N,N-diethylbenzenesulfonamide 
• 1093987-98-4 3-chloro-5-[(6-chloro-3-{[5-(3-cyanophenyl)-1,3,4-oxadiazol-2-yl]methyl}-2-fluorophenyl)oxy]benzonitrile 
• 1093988-00-1 3-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]benzonitrile 

Relevant articles and documents

HETEROCYCLIC ANTIVIRAL COMPOUNDS

The present invention relates to a method of treating an HIV-I infection with a compound according to formula I where R1, R2, R3, R4, R5, are as defined herein.

CHEMICAL COMPOUNDS

The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.